2021
DOI: 10.3390/pharmaceutics13040543
|View full text |Cite
|
Sign up to set email alerts
|

Supercritical Fluid Technology for the Development of 3D Printed Controlled Drug Release Dosage Forms

Abstract: Supercritical CO2 loading of preformed 3D printed drug carriers with active pharmaceutical ingredients (APIs) shows great potential in the development of oral dosage forms for future personalized medicine. We designed 3D printed scaffold like drug carriers with varying pore sizes made from polylactic acid (PLA) using a fused deposition modelling (FDM) 3D printer. The 3D printed drug carriers were then loaded with Ibuprofen as a model drug, employing the controlled particle deposition (CPD) process from supercr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 31 publications
0
3
0
Order By: Relevance
“…Scaffolds with varying pore sizes were made from polylactic acid (PLA) using a FDM 3D printer (German RepRap GmbH, Feldkirchen, Germany). The 3D-printed drug carriers were then loaded with ibuprofen as a model drug, employing the controlled particle deposition (CPD) process from supercritical CO 2 at room temperature, highlighting the benefit of the technology to incorporate thermosensitive drugs [ 120 ].…”
Section: Resultsmentioning
confidence: 99%
“…Scaffolds with varying pore sizes were made from polylactic acid (PLA) using a FDM 3D printer (German RepRap GmbH, Feldkirchen, Germany). The 3D-printed drug carriers were then loaded with ibuprofen as a model drug, employing the controlled particle deposition (CPD) process from supercritical CO 2 at room temperature, highlighting the benefit of the technology to incorporate thermosensitive drugs [ 120 ].…”
Section: Resultsmentioning
confidence: 99%
“…Pharmaceutics 2023, 15, 1301 2 of 14 Despite much effort in drug delivery system development using scCO 2 and 3D-printed biomaterials, there has been limited work reported in literature where 3D printing is combined with scCO 2 to produce a more flexible, tunable, and predictable drug delivery system. Schmid et al completed a study on 3D-printed PLA-based drug release system, using scCO 2 to incorporate ibuprofen into the polymer [9]. Fused deposition modeling, as the 3D-printing method, was employed to produce thin film, spherical and cylindrical samples with varying pore sizes.…”
Section: Introductionmentioning
confidence: 99%
“…To the best of our knowledge, such studies have not been performed on thermoplastic matrices, which are extensively used to develop biomedical implants. Moreover, the increased interest in developing drug-eluting implants and scaffolds of thermoplastics polymers using fused deposition modeling (FDM) 3D printing motivates the comparison of the impregnation methods, to decide which should be used to load the drugs into the filaments or printed device, depending on the desired release profile [20,[38][39][40][41]. In order to select the most appropriate drug loading processes, it is necessary to understand its impact on drug loading, the polymer microstructure, the drug crystalline state, the in vitro polymer behavior, and the drug release profile.…”
Section: Introductionmentioning
confidence: 99%